ELEVAI Labs Inc

ELEVAI Labs (NASDAQ: ELAB) specializes in medical aesthetics and biopharmaceutical drug development, focusing on aesthetic innovations for skin, and treatments tied to obesity and metabolic health. Driven by a commitment to scientific research, we aim to transform personal health and beauty. For more information, please visit www.elevailabs.com. ELEVAI Biosciences Inc., an Elevai Labs company, is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Our lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesitys pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. For more information, please...

Stem cells,exosomes,skincare,aesthetics,physician dispensed,regenerative skincare,dermatology,plastic surgery,post-procedure,skin health,growth factors,and ethical sourcing

Elevai labs inc operates in the Biotechnology research industry.

Elevai labs inc's revenue is 11m - 100m

Elevai labs inc has 11 - 50 employees.